DGX vs ENTX · P/E 22, rev $5.94B vs $58.2M cap
Quest Diagnostics Incorporated (DGX) versus Entera Bio Ltd (ENTX) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Entera Bio Ltd (ENTX) is a biotechnology company listed on US.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported ENTX revenue for 2026-06-30 was $0. Net income was -$10.8M. ENTX currently screens at market cap $58.2M.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. ENTX currently screens at market cap $58.2M.
Not investment advice. Open the DGX and ENTX stock pages for the full models.
Not investment advice.